טוען...
Endothelial human dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling
Tetrahydrobiopterin (BH(4)) is required for NO synthesis and inhibition of superoxide release from eNOS. Clinical trials using BH(4) to treat endothelial dysfunction have produced mixed results. Poor outcomes may be explained by the rapid systemic and cellular oxidation of BH(4). One of the oxidatio...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3748942/ https://ncbi.nlm.nih.gov/pubmed/23707606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2013.04.035 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|